Mylan Inc. (MYL) recently announced that its UK and Italian subsidiaries have launched its generic version of GlaxoSmithKline's (GSK) drug, Epivir (lamivudine, 150 mg and 300 mg). This launch ma ...
via Investopedia.com Headlines http://www.investopedia.com/stock-analysis/Zacks/GenericLaunchesatMylanContinue-AnalystBlog.aspx
8233 Old Courthouse Rd Ste 330 Vienna V.A. 22182
Matt Sileno
The Intuitive Group Inc
No comments:
Post a Comment